Found: 26
Select item for more details and to access through your institution.
Why is There Still Debate About Recommending DPYD‐Testing Before Fluoropyrimidine Treatment?
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 733, doi. 10.1002/cpt.3016
- By:
- Publication type:
- Article
ASCPT NEWS.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 740, doi. 10.1002/cpt.3014
- Publication type:
- Article
In this Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 731, doi. 10.1002/cpt.3013
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 738, doi. 10.1002/cpt.3011
- Publication type:
- Article
Design and Execution of Sustainable Decentralized Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 802, doi. 10.1002/cpt.3009
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling and Simulation of Mavacamten Exposure with Drug–Drug Interactions from CYP Inducers and Inhibitors by CYP2C19 Phenotype.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 922, doi. 10.1002/cpt.3005
- By:
- Publication type:
- Article
Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 825, doi. 10.1002/cpt.2980
- By:
- Publication type:
- Article
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 904, doi. 10.1002/cpt.3002
- By:
- Publication type:
- Article
A Case for Synthetic Data in Regulatory Decision‐Making in Europe.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 795, doi. 10.1002/cpt.3001
- By:
- Publication type:
- Article
Non‐Medical Switching from Tocilizumab to Sarilumab in Rheumatoid Arthritis Patients with Low Disease Activity, an Observational Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 810, doi. 10.1002/cpt.2999
- By:
- Publication type:
- Article
Hybrid Controlled Clinical Trials Using Concurrent Registries in Amyotrophic Lateral Sclerosis: A Feasibility Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 883, doi. 10.1002/cpt.2994
- By:
- Publication type:
- Article
Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 914, doi. 10.1002/cpt.3003
- By:
- Publication type:
- Article
Application of Quantitative Systems Pharmacology to Pediatric Drug Safety Assessment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 748, doi. 10.1002/cpt.2990
- By:
- Publication type:
- Article
Clinical Pharmacology Applications of Real‐World Data and Real‐World Evidence in Drug Development and Approval–An Industry Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 751, doi. 10.1002/cpt.2988
- By:
- Publication type:
- Article
Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 780, doi. 10.1002/cpt.2984
- By:
- Publication type:
- Article
Modeling of Proliferating CD4 and CD8 T‐Cell Changes to Tremelimumab Exposure in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 874, doi. 10.1002/cpt.2992
- By:
- Publication type:
- Article
Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 853, doi. 10.1002/cpt.2983
- By:
- Publication type:
- Article
Population Pharmacokinetics of Oral Azacitidine, and Exposure–Response Analysis in Acute Myeloid Leukemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 845, doi. 10.1002/cpt.2982
- By:
- Publication type:
- Article
Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997–2018.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 836, doi. 10.1002/cpt.2981
- By:
- Publication type:
- Article
Repurposing Artificial Intelligence Tools for Disease Modeling: Case Study of Face Recognition Deficits in Neurodegenerative Diseases.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 862, doi. 10.1002/cpt.2987
- By:
- Publication type:
- Article
Six Years of the US Food and Drug Administration's Postmarket Active Risk Identification and Analysis System in the Sentinel Initiative: Implications for Real World Evidence Generation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 815, doi. 10.1002/cpt.2979
- By:
- Publication type:
- Article
Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 768, doi. 10.1002/cpt.2978
- By:
- Publication type:
- Article
Methotrexate Polyglutamates Exposure – Response Modeling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 893, doi. 10.1002/cpt.2974
- By:
- Publication type:
- Article
Interpretation of Pharmacovigilance Disproportionality Analyses.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 745, doi. 10.1002/cpt.2951
- By:
- Publication type:
- Article
Reply to "Interpretation of Pharmacovigilance Disproportionality Analyses".
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 747, doi. 10.1002/cpt.2950
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 723, doi. 10.1002/cpt.2662
- Publication type:
- Article